Depression is a serious psychological condition that affects approximately 16 million American adults every year and 1 in every 8 adolescents, and it is on the rise in vulnerable groups such as children and the elderly.1-8 Complicating the care of depression is the high rate of treatment resistance, meaning that even while receiving care or taking medication, the individual still experiences symptoms of depression. 3, 9-10 This leaves many patients in need of a solution for their depressive symptoms.
To address the needs of individuals experiencing medication resistant depression, the Life University NeuroLife Institute, in collaboration with the Center for Chiropractic Research and the University of Georgia, are conducting a clinical trial evaluating the effectiveness of a team-based applied clinical neuroscience approach to treatment resistant depression. Individuals may qualify for participation in this research study if they are:
- Over the age of 18
- Have been diagnosed with depression
- Have been on medication for at least 3 months
- Have limited or no relief of depression symptoms
The study will involve visits to the NeuroLife Center on the Life University campus in Marietta, GA. During the 6-weeks of focused care, visits to the center could be required several times per week, and a few separate history and exam assessments with the NeuroLife team may be requested over the 18-week period. Four assessment visits will also be scheduled at the Life University Center for Chiropractic Research (CCR) facility in the Midtown area of Atlanta, Ga. The assessments in the CCR will include non-invasive evaluation of your brain wave patterns using electroencephalography (EEG) along with balance and movement assessments.
Qualified participants receive study treatment and care at no cost and can earn up to $150 over the course of the 18-week study.
For more information or to see if you qualify, contact the NeuroLife center at 770-426-2829.
This study has been approved by the Life University IRB.